Healthcare provider profile · identity verified

Kathryn Ann Huseth

Nurse Practitioner · MINNEAPOLIS, MN · NPI 1366637670

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	441	52
Levothyroxine Sodium	Levothyroxine Sodium	380	46
Sertraline Hcl	Sertraline Hcl	348	42
Atorvastatin Calcium	Atorvastatin Calcium	329	42
Gabapentin	Gabapentin	290	32
Losartan Potassium	Losartan Potassium	282	32
Donepezil Hcl	Donepezil Hcl	241	28
Mirtazapine	Mirtazapine	232	28
Lisinopril	Lisinopril	203	27
Furosemide	Furosemide	198	23
Omeprazole	Omeprazole	198	27
Quetiapine Fumarate	Quetiapine Fumarate	183	25
Metoprolol Succinate	Metoprolol Succinate	166	22
Trazodone Hcl	Trazodone Hcl	160	28
Simvastatin	Simvastatin	146	18
Pantoprazole Sodium	Pantoprazole Sodium	141	15
Eliquis	Apixaban	135	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	122	15
Escitalopram Oxalate	Escitalopram Oxalate	121	17
Potassium Chloride	Potassium Chloride	119	16
Carvedilol	Carvedilol	117	12
Warfarin Sodium	Warfarin Sodium	113	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	105	12
Memantine Hcl	Memantine Hcl	83	13
Xarelto	Rivaroxaban	83	suppressed
Diclofenac Sodium	Diclofenac Sodium	77	21
Latanoprost	Latanoprost	71	12
Duloxetine Hcl	Duloxetine Hcl	70	suppressed
Metformin Hcl	Metformin Hcl	70	suppressed
Nystatin	Nystatin	67	26
Allopurinol	Allopurinol	66	suppressed
Januvia	Sitagliptin Phosphate	65	suppressed
Loperamide	Loperamide Hcl	65	17
Metoprolol Tartrate	Metoprolol Tartrate	64	suppressed
Levetiracetam	Levetiracetam	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Myrbetriq	Mirabegron	59	suppressed
Divalproex Sodium	Divalproex Sodium	56	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	56	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	56	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	55	suppressed
Pravastatin Sodium	Pravastatin Sodium	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Metformin Hcl Er	Metformin Hcl	50	suppressed
Bupropion Xl	Bupropion Hcl	48	suppressed
Prednisone	Prednisone	48	16
Atenolol	Atenolol	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	16
Cephalexin	Cephalexin	43	25
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Olanzapine	Olanzapine	40	suppressed
Glipizide Er	Glipizide	36	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Lamotrigine	Lamotrigine	33	suppressed
Torsemide	Torsemide	33	suppressed
Bumetanide	Bumetanide	32	suppressed
Finasteride	Finasteride	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Glipizide	Glipizide	29	suppressed
Timolol Maleate	Timolol Maleate	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	11
Spironolactone	Spironolactone	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Nyamyc	Nystatin	24	18
Triamcinolone Acetonide	Triamcinolone Acetonide	24	13
Jardiance	Empagliflozin	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Calcitriol	Calcitriol	18	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Travoprost	Travoprost	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Famotidine	Famotidine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Estradiol	Estradiol	14	suppressed
Mesalamine Dr	Mesalamine	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Exemestane	Exemestane	13	suppressed
Hydroxyurea	Hydroxyurea	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lidocaine Hcl	Lidocaine Hcl	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valsartan	Valsartan	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error